Roche bid to recycle Gazyva for lupus nephritis wins FDA breakthrough tag

Roche bid to recycle Gazyva for lupus nephritis wins FDA breakthrough tag
Reuters: Health
Roche has won the U.S. Food and Drug Administration's breakthrough therapy tag for its drug Gazyva in lupus nephritis, the Swiss drugmaker said on Wednesday, boosting its efforts to recycle the 2013-approved lymphoma medicine for new indications.